Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria

Journal of Clinical Investigation

Volumn 103, Issue 8, 1999, Pages 1169-1178

  Pietz, Joachim ^a   Kreis, Roland ^b   Rupp, André ^a   Mayatepek, Ertan ^a   Rating, Dietz ^a   Boesch, Chris ^b   Bremer, Hans Joachim ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLALANINE;

AMINO ACID METABOLISM; AMINO ACID TRANSPORT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN FUNCTION; BRAIN TISSUE; DIET SUPPLEMENTATION; DOPAMINE RELEASE; ELECTROENCEPHALOGRAPHY; HUMAN; HUMAN TISSUE; NEUROTRANSMITTER RELEASE; PATHOPHYSIOLOGY; PHENYLKETONURIA; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0033560647     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI5017     Document Type: Article

References (46)

1. Krause, W., Epstein, C., Averbook, A., Dembure, P., and Elsas, L. 1986. Phenylalanine alters the mean power frequency of electroencephalograms and plasma L-DOPA in treated patients with phenylketonuria. Pediatr. Res. 20:1112-1116.
2. Krause, W., et al. 1985. Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man. J. CBu Invest. 75:40-48.
3. Pietz, J., et al. 1993 EEGs in phenylketonuria. I. Follow-up to adulthood. II. Short-term diet-related changes in EEGs and cognitive function. Dev. Med. Child Neurol. 35:54-64.
4. Lou, H.C. 1985. Large doses of tryptophan and tyrosine as potential therapeutic alternative to dietary phenylalanine restriction in phenylketonuria [letter]. Lancet. 2:150-151.
5. Berry, H.K., Brunner, R.L., Hunt, MM., and White, P.P. 1990. Valine, isoleucine and leucine. A new treatment for phenylketonuria. Am. J. Dis. Child. 144:539-543.
6. Scriver, C.R., Kaufman, S., Eisensmith, R.C., and Woo, S.L.C. 1995. The hyperphenylalaninemias. In The metabolic basis of inherited disease, volume 1. 7th edition. C.R. Scrivet, A.L. Beaudet, W.S. Sly, and D. Valle, editors. McGraw-Hill. New York, NY. 1015-1075.
7. Kaufman, S. 1977. Phenylketonuria: biochemical mechanisms. In Advances in neurochemistry, volume 2. B.W. Agranoff and M.H. Aprison, editors. Plenum Press. New York, NY. 1-132.
8. Novocny, E.J., et al. 1995. In vivo measurement of phenylalanine in human brain by proton nuclear magnetic resonance specrroscopy. Pediatr. Res. 37:244-249.
9. 1H magnetic resonance spectroscopy. J. Magn. Reson. B. 107:242-251.
10. 1H-MR spectroscopy for clinical use. Prog. NMR Spectroscopy. 31:155-195.
11. 1H magnetic resonance spectroscopy. Pediatr. Res. 38:1-7.
12. Guldberg, P., et al. 1998. A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am. J. Hum. Genet. 63:71-79.
13. Lutz, P., Schmidt, H., Frey, G., and Bickel, H. 1982. Standardized loading test with protein for the differentiation of phenylketonuria from hyperphenylalaninemia. J. Inherit. Metab. Dis. 5:29-35.
14. Pietz, J., et al. Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment. Radiology. 201:413-420.
15. Pardridge, W.M. 1988. Phenylalanine transport at the human blood-brain barner. In Dietary phenylalanine and brain function. R.J. Wurtman and E. Ritter-Walker, editors. Birkhäuser. Boston, MA. 56-62.
16. Miller, L., Braun, L.D., Pardridge, W.M., and Oldendorf, W.H. 1985 Kinetic constants for blood-brain barrier amino acid transport in conscious rats. J. Neurochem. 45:1427-1432.
17. Slotboom, J., Boesch, C., and Kreis, R. 1998. Versatile frequency domain fitting using time domain models and prior knowledge. Magn. Reson. Med. 39:899-311.
18. Pardridge, W.M. 1998 Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids. Neurochem. Res. 23:635-644.
19. Pardridge, W.M., and Oldendorf, W.H. 1975. Kinetic analysis of blood-brain barrier transport of amino acids. Biochim. Biophys. Acta. 401:128-136.
20. Smith, Q.R., Momma, S., Aoyagi, M., and Rapoport, S.I. 1987. Kinetics of neutral amino acid transport across the blood-brain barrier. J. Neurochem. 49:1651-1658.
21. Hargreaves, K.M., and Pardridge, W.M. 1988. Neutral amino acid transport at the human blood-brain barrier. J. Biol. Chem. 263:19392-19397.
22. Herrero, E., Aragon, M.C., Giminez, C., and Valdivieso, F. 1983. Inhibition by L-phenylalanine of tryptophan transport by synaptosomal plasma membrane vesicles: implications in the pathogenesis of phenylketonuria. J. Inherit. Metab. Dis. 6:32-35.
23. Knudsen, G.M., Pettigrew, K.D., Patlak, C.S., Hertz, M.M., and Paulson, O.B. 1990. Asymmetrical transport of amino acids across the blood-brain barrier in humans. J. Cereb. Blood Flow Metab. 10:698-706.
24. Lajtha, A.L. Maker, H.S., and Clarke, D.D. 1981. Metabolism and transport of carbohydrates and amino acids. In Basic neurochemistry. G.J. Siegel, R.W. Albers, B.W. Agranoff, and R Katzman, editors. 3rd edition. Little, Brown and Co. Boston, MA. 329-352.
25. Knudsen, G.M., Hasselbalch, S., Toft, P.B., and Christensen, E. 1995. Blood-brain barrier transport of amino acids in healthy controls and in patients with phenylketonuria. J. Inherit. Metab. Dis. 18:653-664.
26. Shulkin, B.L., Betz, A.L., Koeppe, R.A., and Agranoff, B.W. 1995. Inhibition of neutral amino acid transport across the human blood-brain barrier by phenylalanine. J. Neurochem. 64:1252-1257.
27. Möller, H.E., et al. 1997. Kinetics of phenylalanine transport at the human blood-brain barrier investigated in vivo. Brain Res. 778:329-337.
28. 1H NMR studies of glucose transport in the human brain. J. Cereb. Blood Flow Metab. 16:427-438.
29. Hughes, J.V., and Johnson, T.C. 1978. Abnormal amino acid metabolism and brain protein synthesis during neural development. Neurochem. Res. 3:381-399.
30. Binek-Singer, P.A., and Johnson, T.C. 1982. The effects of chronic hyperphenylalaninaemia on mouse brain protein synthesis can be prevented by other amino acids. Biochem. J. 206:407-414.
31. Dingledine, R., and McBain, C.J. 1993. Excitatory amino acid neurotransmitters. In Basic neurochemistry. G.J. Siegel, B.W. Agranoff, R.W. Albers, and R. Katzman, editors. 5th edition. Raven Press. New York, NY. 367-387.
32. DeLorey, T.M., and Olsen, R.W. 1993. GABA and glycine. In Basic neurochemistry. G.J. Siegel, B.W. Agranoff, R.W. Albers, and R. Katzman, editors. 5th edition. Raven Press. New York, NY. 389-399.
33. Welsh, M.C., Pennington, B.F., Ozonoff, S., Rouse, B., McCabe E.R. 1990. Neuropsychology of early-treated phenylketonuria: specific executive function deficits. Child Dev. 61:1697-1713.
34. Bickel, H., Gerrard, J., and Hickmans, E.M. 1954. The influence of phenylalanine intake on the chemistry and behaviour of a phenylketonuric child. Acta Paediatr. Scad. 43:64-77.
35. Medical Research Council Working Party on Phenylketonuria. 1993. Recommendations on the dietary management of phenylketonuria. Arch. Dis. Child. 68:426-427.
36. Weglage, J., Fünders, B., Wilken, B., van Teeffelen-Heithoff, A., Ullrich, K. 1993. Treatment of phenylketonuria: wish and reality. Monatsschr. Kinderheilkd. 141:670-674.
37. Pietz, J., et al. 1997. Psychiatric disorders in adult patients with early-treated phenylketonuria. Pediatrics. 99:34-350
38. Pietz, J., et al. 1995. Effect of high-dose tyrosine supplementation in adults with phenylketonuria. J. Pediatr. 127:1-8.
39. Berry, H.K., Bofinger, M.K., Hunt, M.M., Phillips, P.J. and Guilfoile, M.B. 1982. Reduction of cerebrospinal fluid phenylalanine after oral administration of valine, isoleucine, and leucine. Pediatr. Res. 16:751-755.
40. Vorhees, C.V., and Berry, H.K. 1989. Branched chain amino acids improve complex maze learning in rat offspring prenatally exposed to hyperphenylalaninemia: implications for maternal phenylketonuria. Pediatr. Res. 25:568-572.
41. Hommes, F.A. 1989. The role of the blood-brain barrier in the aetiology of permanent brain dysfunction in hyperphenylalaninaemia. J. Inherit. Metab. Dis. 12:41-46.
42. Pratt, O.E. 1982. Transport inhibition in the pathology of phenylketonuria and other inherited metabolic diseases. J. Inherit. Metab. Dis. 5(Suppl. 2):75-81.
43. Dotremont, H., Francois, B., Diels, M., and Gillis, P. 1995. Nutritional value of essential amino acids in the treatment of adults with phenylketonuria. J. Inherit. Metab. Dis. 18:127-130.
44. Huether, G., Kaus, R., and Neuhoff, V. 1985. Amino acid depletion in the blood and brain tissue of hyperphenylalaninemic rats is abolished by the administration of additional lysine: a contribution to the understanding of the metabolic defects in phenylketonuria. Biochem. Med. 33:334-341.
45. Ris, M.D., Williams, S.E., Hunt, M.M., Berry, H.K., and Leslie, N. 1994. Early-treated phenylketonuria: adult neuropsychologic outcome. J. Pediatr. 124:388-392.
46. Mönch, E., Herrmann, M.-E., Brösicke, H., Schöffer, A., and Keller, M. 1996. Utilisation of amino acid mixtures in adolescents with phenylketonuria. Eur. J. Pediatr. 155(Suppl. 1):S115-S120.